Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vanda Pharmaceuticals Inc. (GB:0LKB)
LSE:0LKB
Vanda (0LKB) Share Price & Analysis
0 Followers
0LKB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.30 - $6.84
Previous Close$4.78
Volume8.97K
Average Volume (3M)15.62K
Market Cap
$277.60M
Enterprise Value-$103.65M
Total Cash (Recent Filing)$388.26M
Total Debt (Recent Filing)$7.01M
Price to Earnings (P/E)N/A
Beta0.59
Next Earnings
May 08, 2024EPS Estimate
$0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding57,537,499
10 Day Avg. Volume1
30 Day Avg. Volume15,624
Standard Deviation0.14
R-Squared0.04
Alpha0.00538
Financial Highlights & Ratios
Price to Book (P/B)0.65
Price to Sales (P/S)4.36
Price to Cash Flow (P/CF)-18.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.54
Enterprise Value/Gross Profit-0.58
Enterprise Value/Ebitda-11.58
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Vanda News
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
2.66% Other Institutional Investors
97.34% Public Companies and
Individual Investors
0LKB FAQ
What was Vanda Pharmaceuticals Inc.’s price range in the past 12 months?
Vanda Pharmaceuticals Inc. lowest share price was $3.29 and its highest was $6.84 in the past 12 months.
What is Vanda Pharmaceuticals Inc.’s market cap?
Currently, no data Available
When is Vanda Pharmaceuticals Inc.’s upcoming earnings report date?
Vanda Pharmaceuticals Inc.’s upcoming earnings report date is May 08, 2024 which is in 4 days.
How were Vanda Pharmaceuticals Inc.’s earnings last quarter?
Vanda Pharmaceuticals Inc. released its earnings results on Feb 07, 2024. The company reported -$0.04 earnings per share for the quarter, beating the consensus estimate of -$0.09 by $0.05.
Is Vanda Pharmaceuticals Inc. overvalued?
According to Wall Street analysts Vanda Pharmaceuticals Inc.’s price is currently Overvalued.
Does Vanda Pharmaceuticals Inc. pay dividends?
Vanda Pharmaceuticals Inc. does not currently pay dividends.
What is Vanda Pharmaceuticals Inc.’s EPS estimate?
Vanda Pharmaceuticals Inc.’s EPS estimate is $0.05.
How many shares outstanding does Vanda Pharmaceuticals Inc. have?
Currently, no data Available
What happened to Vanda Pharmaceuticals Inc.’s price movement after its last earnings report?
Vanda Pharmaceuticals Inc. reported an EPS of -$0.04 in its last earnings report, beating expectations of -$0.09. Following the earnings report the stock price went up 14.09%.
Which hedge fund is a major shareholder of Vanda Pharmaceuticals Inc.?
Among the largest hedge funds holding Vanda Pharmaceuticals Inc.’s share is Graham Capital Management, L.P.. It holds Vanda Pharmaceuticals Inc.’s shares valued at 107K.
---
Vanda Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
GB:0LKB Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $512.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-25.81%
12-Months-Change
Fundamentals
Return on Equity
0.47%
Trailing 12-Months
Asset Growth
2.24%
Trailing 12-Months
Company Description
Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
---
0LKB Earnings Call
Q4 2024
0:00 / 0:00
---
Technical Analysis
---